The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C. Townsend, Michelle A. Kelliher, Mark A. Murakami et al.|Cancer Cell|2016Cited by 304
Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical modelsSamuel Y. Ng, Raphael Koch, Noriaki Yoshida et al.|Nature Communications|2018Cited by 114
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceElizabeth C. Townsend, Michelle A. Kelliher, Mark A. Murakami et al.|Cancer Cell|2016Cited by 78
Biomarker-driven strategy for MCL1 inhibition in T-cell lymphomasRaphael Koch, David M. Weinstock, J. Paul Secrist et al.|Blood|2018Cited by 63
Dynamic BH3 Profiling Reveals Novel Therapeutic Strategies for the Treatment of Double-Hit LymphomaJennifer L. Crombie, Anthony Letai, Chen Lossos et al.|Blood|2017Cited by 2